PULMONARY DISEASE, CHRONIC OBSTRUCTIVE

This study tests a new medicine called depemokimab for people with moderate to severe COPD who have a specific type of inflammation. The goal is to see if adding this drug to standard treatment can reduce the number of serious flare-ups. About 1,200 participants will receive eith…

This study tests whether clinical pharmacists can provide COPD care that is as good as care from lung specialists. About 4,000 veterans with COPD will receive recommendations from either a pharmacist or a specialist through their primary care doctor. The goal is to see if pharmac…

This study tests an experimental medicine called depemokimab in 960 adults aged 40-80 with moderate to severe COPD and high levels of a certain white blood cell (eosinophils). The goal is to see if adding this drug to standard treatment can reduce the number of moderate or severe…

This study tests an experimental drug called depemokimab in adults aged 40-80 with moderate to severe COPD and type 2 inflammation. The goal is to see if adding this medicine to standard care can reduce the number of moderate or severe flare-ups (exacerbations) that require stero…

This study analyzes data from 2,000 people with moderate to severe COPD who started taking the triple-combination inhaler BGF as part of their normal care. Researchers will compare patients' self-reported breathing and quality-of-life scores at 3 months, 1 month, and 12 months af…

This study looks at whether a higher dose of aspirin can help people with COPD by reducing inflammation caused by blood platelets. Researchers will test two different doses in 48 former smokers with COPD to see which one works better. The goal is to find the right dose for a futu…

This study looks at whether measuring carbon dioxide in a person's breath (EtCO2) can help doctors quickly tell how serious a COPD attack is. Researchers will monitor 240 adults who come to the emergency room with breathing trouble and a history of COPD. If successful, this simpl…